Drug Profile
CHF 1355
Latest Information Update: 20 May 1998
Price :
$50
*
At a glance
- Originator Chiesi
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 20 May 1998 Discontinued-Preclinical for Epilepsy in Italy (Unknown route)
- 28 Jan 1997 No-Development-Reported for Epilepsy in Italy (Unknown route)